Treatment of Aggressive Dementia

Assessment and Identification

• The American Geriatrics Society recommends screening individuals with dementia for behavior changes through interviews with the patient, family members, and healthcare team members 1
• Investigate and treat potential underlying causes of new behavioral changes, such as pain or urinary tract infections, before implementing specific treatments 1
• Assess safety risks related to cognitive status, including decision-making capacity, behavioral status, environment, fall risk, and activities of daily living 1

Non-Pharmacological Interventions

• Implement structured and tailored activities individualized to current capabilities and previous interests 1
• Use activity-based interventions, such as Montessori activities, to increase positive affect and reduce agitation 1
• Apply behavior modification techniques, including graded assistance, practice, and positive reinforcement to increase functional independence 3
• Provide psychoeducational interventions for caregivers to develop problem-focused coping strategies 4, 5

Pharmacological Interventions

• The American Geriatrics Society recommends using antipsychotics when behaviors pose significant safety risks or cause severe distress 3, 6
• Atypical antipsychotics, such as risperidone, olanzapine, and quetiapine, are better tolerated than traditional agents like haloperidol 3, 6
• Consider selected antidepressants, such as tricyclics, MAO-B inhibitors, and SSRIs, for treating depression in dementia patients 3
• Cholinesterase inhibitors, such as donepezil and galantamine, may help reduce behavioral symptoms in mild to moderate dementia 3
• Memantine may be beneficial for behavioral symptoms in moderate to severe dementia 7

Implementation and Special Considerations

• Rule out medical causes, such as pain or infection, and identify specific triggers for aggressive behavior 2
• Assess safety risks for patient and caregivers 1
• Provide caregiver education and support 4
• Consider dementia-friendly environmental modifications to reduce agitation triggers 5
• Ensure regular reassessment of both non-pharmacological and pharmacological interventions 7
• Be aware that estrogen should not be prescribed to treat Alzheimer's disease 3